Liao, K., Hwang, B., Kuo, Y., Liu, C., & Lai, S. (2022). Metformin, pioglitazone and gout risk. Pharmacoepidemiology and drug safety, 31(10), 1127-1128. https://doi.org/10.1002/pds.5516
Chicago Style (17th ed.) CitationLiao, Kuan‐Fu, Bing‐Fang Hwang, Yu‐Hung Kuo, Chiu‐Shong Liu, and Shih‐Wei Lai. "Metformin, Pioglitazone and Gout Risk." Pharmacoepidemiology and Drug Safety 31, no. 10 (2022): 1127-1128. https://doi.org/10.1002/pds.5516.
MLA (9th ed.) CitationLiao, Kuan‐Fu, et al. "Metformin, Pioglitazone and Gout Risk." Pharmacoepidemiology and Drug Safety, vol. 31, no. 10, 2022, pp. 1127-1128, https://doi.org/10.1002/pds.5516.
Warning: These citations may not always be 100% accurate.